EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Major Vault Protein/Lung Resistance-Related Protein: A Novel Biomarker for Inflammation and Acute Infections

John G Routsias, Dionysia Marinou, Maria Mavrouli, Athanasios Tsakris iD, Vassiliki C Pitiriga iD

Microorganisms · 25.08.2024 · 12 (9) · 1762

DOI: 10.3390/microorganisms12091762 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microorganisms, online erschienen am 25.08.2024. Verfasst von John G Routsias und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Vault particles are large cytoplasmic ribonucleoprotein particles that participate in inflammation. The aim of this study was to assess the diagnostic and prognostic value of major vault protein (MVP) in patients with inflammation, in order to determine whether MVP could be used as a biomarker for infection or inflammation. We also aimed to compare the diagnostic impact of MVP compared to other conventional measurements, such as CRP or white blood cell (WBC) counts.

Methods

CRP and MVP levels were measured in 111 sera samples from 85 patients with inflammation admitted to a tertiary-care hospital and 26 healthy individuals during an 18-month period (2019–2020), using nephelometry and a custom MVP sandwich ELISA assay, respectively. In addition, WBC counts were measured using a commercial assay.

Results

MVP levels were found to be elevated in patients with inflammation compared to healthy individuals (p < 0.0001). Moreover, MVP levels were higher in patients with inflammation due to an infectious etiology compared to those with non-infectious etiology (p = 0.0006). MVP levels significantly decreased during the first four days of infection in response to antibiotic treatment, while CRP levels showed a less-sensitive decline. An ROC curve analysis demonstrated that MVP and CRP have similarly high diagnostic accuracy, with AUCs of 0.955 and 0.995, respectively, followed by WBCs with an AUC of 0.805.

Conclusions

The ROC curves demonstrated that MVP has the potential to serve as a diagnostic biomarker for inflammation and infection. Additionally, MVP levels may reflect the efficacy of antibiotic treatment.

Schlagwörter

Stichwörter der Autor:innen

MVPbiomarkerinfectioninflammationmajor vault proteinvaults

Autor:innen und Institutionen

  • Department of Microbiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.

ORCID-Profile: Athanasios Tsakris, Vassiliki C Pitiriga

Zitieren

APA

Routsias, J. G., Marinou, D., Mavrouli, M., Tsakris, A., & Pitiriga, V. C. (2024). Major Vault Protein/Lung Resistance-Related Protein: A Novel Biomarker for Inflammation and Acute Infections. Microorganisms, 12(9), 1762. https://doi.org/10.3390/microorganisms12091762

Vancouver

Routsias JG, Marinou D, Mavrouli M, Tsakris A, Pitiriga VC. Major Vault Protein/Lung Resistance-Related Protein: A Novel Biomarker for Inflammation and Acute Infections. Microorganisms. 2024;12(9):1762. doi:10.3390/microorganisms12091762

BibTeX
@article{Routsias2024,
  author = {Routsias, John G and Marinou, Dionysia and Mavrouli, Maria and Tsakris, Athanasios and Pitiriga, Vassiliki C},
  title = {Major Vault Protein/Lung Resistance-Related Protein: A Novel Biomarker for Inflammation and Acute Infections},
  journal = {Microorganisms},
  year = {2024},
  volume = {12},
  number = {9},
  pages = {1762},
  doi = {10.3390/microorganisms12091762}
}
Kostenlos starten →